Abstract

BackgroundTotal knee arthroplasty (TKA) is an established procedure for relieving pain and improving function. The Press Fit Condylar Cobalt Chrome Sigma (PFCSCC) Total Knee System was introduced by Depuy, Johnson & Johnson in 2006, as an update of their existing PFC Sigma design intended to reduce backside wear. MethodsTo identify any significant early failures following the introduction of this knee system, we prospectively identified all patients undergoing TKA with the PFCSCC over a one-year period. Clinical and demographic patient data, American Knee Society scores, Oxford Knee scores, SF-12 scores and radiographic data were recorded pre-operatively and at three and five years post-operatively. Results233 patients underwent 249 primary TKA's with the PFCSCC. Seventeen patients (19 TKAs) died before the last review and 29 patients (30 knees) were lost to follow up. The mean age was 66.6 (range 34–80) with 47.6% male. Mean five year follow-up was 1836days (range 1530–2307). Five knees (2.2%) were revised for infection with three revised for pain. The 5-year survival rate was 96.6% and 98.6% for aseptic failure. American Knee Society Score (AKSS) was 32.6 (0–86.6) preoperatively and 80.7 (29–95) 5 years post-operatively P<0.001. OKS was 20.9 (7–38) preoperatively and 36.4 (10–48) at 5 years P<0.001. ConclusionWe report the first five year outcome of this design change, which demonstrates a good early survivorship when compared to the previous PFC Sigma design.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.